# CHI Health

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/chi-health/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 56 |
| Citations | 23,406 |
| City | Omaha |
| Country | US |
| Description | CHI Health is a research organisation in Omaha, US. OpenAlex records 1,378 works and 23,406 citations for it. 544 researchers list it as their most recent affiliation. |
| Homepage | https://www.chihealth.com |
| OpenAlex ID | https://openalex.org/I2802665030 |
| Researchers | 544 |
| ROR ID | https://ror.org/05kph6k12 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q4714382 |
| Works | 1,378 |

## University papers

Showing 12 of 13.

- [Revised Equations for Estimated GFR From Serum Creatinine in Japan](https://scholariq.org/papers/revised-equations-for-estimated-gfr-from-serum-creatinine-in-japan/)
- [Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer](https://scholariq.org/papers/japanese-society-for-cancer-of-the-colon-and-rectum-jsccr-guidelines-2016-for/)
- [Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-paclitaxel-versus-placebo-plus-paclitaxel-in-patients-with/)
- [Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer](https://scholariq.org/papers/japanese-society-for-cancer-of-the-colon-and-rectum-jsccr-guidelines-2019-for/)
- [Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-for-the-treatment-of-advanced-non-functional-neuroendocrine-tumours/)
- [Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease](https://scholariq.org/papers/estimation-of-glomerular-filtration-rate-by-the-mdrd-study-equation-modified-for/)
- [Prevalence of chronic kidney disease in the Japanese general population](https://scholariq.org/papers/prevalence-of-chronic-kidney-disease-in-the-japanese-general-population/)
- [Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan](https://scholariq.org/papers/modification-of-the-modification-of-diet-in-renal-disease-mdrd-study-equation/)
- [Slower Decline of Glomerular Filtration Rate in the Japanese General Population: A Longitudinal 10-Year Follow-Up Study](https://scholariq.org/papers/slower-decline-of-glomerular-filtration-rate-in-the-japanese-general-population/)
- [Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial](https://scholariq.org/papers/survival-outcomes-following-laparoscopic-versus-open-d3-dissection-for-stage-ii/)
- [Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient](https://scholariq.org/papers/prevalence-of-chronic-kidney-disease-ckd-in-the-japanese-general-population/)
- [Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice](https://scholariq.org/papers/down-regulation-of-smad7-expression-by-ubiquitin-dependent-degradation/)

## University top topics

Showing 8 of 25.

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.